We are no longer accepting new Avandia cases.
Baum, Hedlund, Aristei & Goldman's drug department is representing many individuals who were taking Avandia and suffered a heart attack or coronary artery blockage that required a stent or bypass surgery. The firm is also representing individuals who suffered from a stroke or congestive heart failure while taking the drug. Our firm has represented thousands of victims of pharmaceutical drug-induced injuries and death for more than 25 years.
Avandia was pulled from pharmacies on November 18, 2011.
Our drug team has filed Avandia lawsuits against GlaxoSmithKline. At an FDA hearing in July of 2007, FDA Scientist, David Graham, stated that he thinks Avandia should be withdrawn from the market.
Baum Hedlund has extensively litigated antidepressant drug cases against Avandia maker, GlaxoSmithKline, and in the process of that litigation, has acquired a number of internal GSK documents regarding Avandia. GSK may have used a similar method for concealing known side effects of Avandia, which Baum Hedlund discovered while litigating against GSK in Paxil cases.
While representing our clients, we dig deep into drug company files to discover the truth about what the company knew about the drug’s risks, when the company knew of those risks and what efforts, if any, the company took to hide those risks. Only through legal action can anyone gain access to this type of information.
From publicly available information, Cleveland Clinic cardiologist Dr. Steven Nissen and his colleague Kathy Wolski, found, after evaluating 42 studies that compared patients taking Avandia with patients not using the drug, that the risk of heart attack increased 43 percent among patients taking Avandia and determined that there is also a 64 percent increased risk of dying from cardiovascular causes while taking Avandia.
For more information about Avandia or to find out more about your legal rights, please visit www.avandia-heart-lawyers.com.